RESUMEN
Human cerebral organoids (HCOs) are an in vitro model of early neural development, aimed at modelling and understanding brain development and neurological disorders. In just a few years there has been rapid and considerable progress in the attempt to create a brain model capable of showcasing the characteristics of the human brain. There are still strong limitations to address, including the absence of vascularization which makes it difficult to feed the central layers of the organoid. Nevertheless, some important features of the nervous system have recently been observed in cerebral organoids: they manifest electrical activity (i.e. communication between neurons), are sensitive to light stimulation and are able to connect to a spinal cord by sending impulses that make a muscle contract. Recent data show that cortical organoid network development at ten months resembles some preterm babies EEG patterns. Although cerebral organoids are not close to human brains so far due to their extremely simplified structure, this state of things gives rise to ethical concerns about the creation and destructive experimental use of human cerebral organoids. Particularly, one can wonder whether a human cerebral organoid could develop some degree of consciousness and whether, under certain conditions, it could acquire its own moral status with the related rights. In this article, I discuss the conditions under which HCOs could be granted their own moral status. For this purpose, I consider the hypothesis that HCOs might develop a primitive form of consciousness and investigate the ways in which it could be detected. In light of all this, I finally point out some cautionary measures that could be introduced into research on and with human cerebral organoids.
Asunto(s)
Técnicas de Cultivo de Célula/ética , Estado de Conciencia/ética , Organoides/fisiología , Encéfalo/fisiología , Estado de Conciencia/fisiología , Humanos , Células Madre Pluripotentes Inducidas/fisiología , Condición Moral , Neurogénesis/fisiología , Neuronas/fisiología , Organoides/metabolismoAsunto(s)
Técnicas de Cultivo de Célula , Organoides/citología , Animales , Bioingeniería/ética , Bioingeniería/métodos , Bioingeniería/tendencias , Técnicas de Cultivo de Célula/ética , Técnicas de Cultivo de Célula/métodos , Técnicas de Cultivo de Célula/tendencias , Células Cultivadas , Experimentación Humana/ética , Humanos , Células Madre Pluripotentes Inducidas/citología , Células Madre Pluripotentes Inducidas/fisiología , Organoides/patología , Obtención de Tejidos y Órganos/ética , Obtención de Tejidos y Órganos/métodos , Obtención de Tejidos y Órganos/tendenciasRESUMEN
Results obtained from completed and on-going clinical studies indicate huge therapeutic potential of stem cell-based therapy in the treatment of degenerative, autoimmune and genetic disorders. However, clinical application of stem cells raises numerous ethical and safety concerns. In this review, we provide an overview of the most important ethical issues in stem cell therapy, as a contribution to the controversial debate about their clinical usage in regenerative and transplantation medicine. We describe ethical challenges regarding human embryonic stem cell (hESC) research, emphasizing that ethical dilemma involving the destruction of a human embryo is a major factor that may have limited the development of hESC-based clinical therapies. With previous derivation of induced pluripotent stem cells (iPSCs) this problem has been overcome, however current perspectives regarding clinical translation of iPSCs still remain. Unlimited differentiation potential of iPSCs which can be used in human reproductive cloning, as a risk for generation of genetically engineered human embryos and human-animal chimeras, is major ethical issue, while undesired differentiation and malignant transformation are major safety issues. Although clinical application of mesenchymal stem cells (MSCs) has shown beneficial effects in the therapy of autoimmune and chronic inflammatory diseases, the ability to promote tumor growth and metastasis and overestimated therapeutic potential of MSCs still provide concerns for the field of regenerative medicine. This review offers stem cell scientists, clinicians and patient's useful information and could be used as a starting point for more in-depth analysis of ethical and safety issues related to clinical application of stem cells.
Asunto(s)
Investigación Biomédica/ética , Trasplante de Células/ética , Ingeniería Genética/ética , Terapia Genética/ética , Células Madre Embrionarias Humanas/trasplante , Animales , Investigación Biomédica/métodos , Técnicas de Cultivo de Célula/ética , Técnicas de Cultivo de Célula/métodos , Diferenciación Celular/genética , Trasplante de Células/métodos , Quimera/genética , Embrión de Mamíferos/citología , Ingeniería Genética/efectos adversos , Ingeniería Genética/métodos , Terapia Genética/efectos adversos , Terapia Genética/métodos , Humanos , Células Madre Pluripotentes Inducidas/trasplante , Trasplante de Células Madre Mesenquimatosas/efectos adversos , Trasplante de Células Madre Mesenquimatosas/ética , Medicina Regenerativa/ética , Medicina Regenerativa/métodosAsunto(s)
Células HeLa , Obtención de Tejidos y Órganos/legislación & jurisprudencia , Técnicas de Cultivo de Célula/ética , Técnicas de Cultivo de Célula/historia , Historia del Siglo XX , Humanos , National Institutes of Health (U.S.)/ética , National Institutes of Health (U.S.)/historia , National Institutes of Health (U.S.)/legislación & jurisprudencia , Obtención de Tejidos y Órganos/ética , Obtención de Tejidos y Órganos/historia , Estados UnidosRESUMEN
Clinically compliant human embryonic stem cells (hESCs) should be developed in adherence to ethical standards, without risk of contamination by adventitious agents. Here we developed for the first time animal-component free and good manufacturing practice (GMP)-compliant hESCs. After vendor and raw material qualification, we derived xeno-free, GMP-grade feeders from umbilical cord tissue, and utilized them within a novel, xeno-free hESC culture system. We derived and characterized three hESC lines in adherence to regulations for embryo procurement, and good tissue, manufacturing and laboratory practices. To minimize freezing and thawing, we continuously expanded the lines from initial outgrowths and samples were cryopreserved as early stocks and banks. Batch release criteria included DNA-fingerprinting and HLA-typing for identity, characterization of pluripotency-associated marker expression, proliferation, karyotyping and differentiation in-vitro and in-vivo. These hESCs may be valuable for regenerative therapy. The ethical, scientific and regulatory methodology presented here may serve for development of additional clinical-grade hESCs.
Asunto(s)
Técnicas de Cultivo de Célula/métodos , Células Madre Embrionarias/citología , Técnicas de Cultivo de Célula/ética , HumanosRESUMEN
Fifty years after Henrietta Lacks died of aggressive glandular cervical cancer, the first cell line - HeLa cell line - is the workhorse of laboratories everywhere. It helped to produce drugs for numerous diseases, including poliomyelitis, Parkinson's, leukemias. But they are so outrageously robust that they contaminated hundred of other cell lines, as far away as Russia. For decades, biologists worked with contaminated cell lines and today, the problem is not yet solved. But the story of HeLa cells is also a moving reflection of racial and ethical issues in medicine in the late half-twentieth century in the USA.
Asunto(s)
Biología Celular/historia , Técnicas de Cultivo de Célula/historia , Células HeLa , Oncología Médica/historia , Adenocarcinoma/historia , Adenocarcinoma/patología , Artefactos , Baltimore , Técnicas de Cultivo de Célula/ética , Técnicas de Cultivo de Célula/normas , Línea Celular , Familia , Femenino , Células HeLa/trasplante , Historia del Siglo XX , Experimentación Humana/ética , Experimentación Humana/historia , Humanos , Consentimiento Informado/legislación & jurisprudencia , Periodismo Médico , Derechos del Paciente/historia , Derechos del Paciente/legislación & jurisprudencia , Bancos de Tejidos , Recolección de Tejidos y Órganos/legislación & jurisprudencia , Neoplasias del Cuello Uterino/historia , Neoplasias del Cuello Uterino/patología , Adulto JovenRESUMEN
Fetal bovine serum (FBS) is a ubiquitously used essential supplement in cell culture media. However, there are serious scientific and ethical concerns about the use of FBS regarding its harvest and production. During the last three decades, FBS could be substituted by other supplements or by the use of defined chemical components in serum-free cell culture. A number of serum-free medium formulations have been described for mammalian and insect cell lines as well as for primary cultures. However, the switch to serum-free media still demands a time-consuming literature survey and a manufacturer search for appropriate medium formulations, respectively. Here we present the second collection of commercially available serum-free media in an updated, freely accessible interactive online database. Searches for serum-free media and continuous cell lines already adapted to serum-free culture can be performed according to various criteria. These include the degree of chemical definition, e.g. serum-free (SF), animal-derived component free (ADCF) or chemically defined (CD), and the type of medium, e.g. basal media, medium supplements, or full replacement media. In order to specify the cell lines that are adapted to serum-free media, search terms like species, organ, tissue, cell type and disease can be used. All commercially available serum-free media and adapted cell lines currently available from major distributors (e.g. ATCC, ECACC and DMSZ) are included in the database. Despite an extensive search for serum-free media and adapted cell lines, detailed information from certain companies and suppliers is still lacking and is specifically highlighted. It is intended to create a platform for the interactive exchange of information and experience by experts in the field in order to continuously improve and extend the serum-free online database. The database is accessible at http://www.goodcellculture.com/
Asunto(s)
Técnicas de Cultivo de Célula/métodos , Medio de Cultivo Libre de Suero , Bases de Datos Factuales , Internet , Alternativas a las Pruebas en Animales , Bienestar del Animal , Técnicas de Cultivo de Célula/éticaRESUMEN
In this issue of Cell Stem Cell, Chung et al. (2008) remove a single blastomere to generate a human embryonic stem cell (hESC) line without prejudicing the development of the biopsied embryo. Their method stimulates new ideas about hESC formation, but ethicopolitical concerns remain.
Asunto(s)
Discusiones Bioéticas , Blastocisto/citología , Línea Celular , Investigaciones con Embriones/ética , Células Madre Embrionarias/citología , Animales , Técnicas de Cultivo de Célula/ética , Técnicas de Cultivo de Célula/métodos , Separación Celular , Investigaciones con Embriones/legislación & jurisprudencia , Humanos , RatonesRESUMEN
The authors argue that a new method of deriving embryonic stem cell lines, which could be performed in conjunction with preimplantation genetic diagnosis, is unlikely to solve ethical concerns.
Asunto(s)
Blastómeros/citología , Diferenciación Celular , Separación Celular/ética , Separación Celular/métodos , Investigaciones con Embriones/ética , Células Madre/citología , Animales , Biopsia , Técnicas de Cultivo de Célula/ética , Técnicas de Cultivo de Célula/métodos , Células Cultivadas , Cariotipificación , Ratones , Teratoma , Trofoblastos/citología , Estados UnidosRESUMEN
Talk of policy has dominated talk of science for those interested in embryonic stem cell science. But research is continuing, and the advances are making clear why embryonic stem cells are such an important scientific and medical resource.
Asunto(s)
Investigación Biomédica/tendencias , Trasplante de Células Madre/tendencias , Células Madre/fisiología , Enfermedad de Alzheimer/etiología , Enfermedad de Alzheimer/genética , Animales , Investigación Biomédica/ética , Investigación Biomédica/legislación & jurisprudencia , Técnicas de Cultivo de Célula/ética , Técnicas de Cultivo de Célula/tendencias , Diferenciación Celular/genética , Linaje de la Célula/genética , Modelos Animales de Enfermedad , Humanos , Óvulo/citología , Óvulo/fisiología , Trasplante de Células Madre/ética , Trasplante de Células Madre/legislación & jurisprudencia , Células Madre/citologíaRESUMEN
Despite considerable progress in the development of cell culture techniques, including the development of the serum- and protein-free media that now routinely support hybridoma and mammalian cell growth, fetal bovine serum (FBS) supplemented media are still commonly used: a practice that raises ethical, scientific and safety concerns. The use of FBS in hybridoma culture media is examined here, with regards to the development and production of monoclonal antibodies (mAbs), and it is our recommendation that researchers adopt serum-free cell culture methods to reduce animal use in this area.
Asunto(s)
Alternativas al Uso de Animales , Técnicas de Cultivo de Célula/ética , Medio de Cultivo Libre de Suero , Hibridomas , Salud Laboral , Alternativas al Uso de Animales/ética , Alternativas al Uso de Animales/tendencias , Animales , Bovinos , Técnicas de Cultivo de Célula/métodos , HumanosRESUMEN
Embryonic stem cells (ESCs), which are isolated from the inner cell mass of the blastocyst stage embryo, have the potential to give rise to an entire organism and to generate every body cell type. Much improvement has been made in the field of induction and differentiation of ESCs during the last two years, such as the ESCs differentiation into germ cells (2003) and the cloning of human ESCs (2004), both of which were chosen respectively as one of the top ten achievements evaluated by academic journals. Great attention was also paid to the research of the new genes which could maintain ESCs in the undifferentiated state and the research of the induction and differentiation of ESCs.
Asunto(s)
Diferenciación Celular/fisiología , Células Madre Embrionarias/citología , Células Madre Embrionarias/fisiología , Animales , Técnicas de Cultivo de Célula/ética , Técnicas de Cultivo de Célula/métodos , Técnicas de Cultivo de Célula/tendencias , Diferenciación Celular/genética , Células Cultivadas , HumanosRESUMEN
Parkinson's disease (PD) is a neurodegenerative disease characterised by a loss of midbrain dopaminergic (DA) neurons. Transplantation of DA neurons represents a promising treatment for PD, and embryonic stem (ES) cells are a good candidate source for DA neurons. However, although recent reports have demonstrated that DA neurons can be efficiently induced from ES cells and function therapeutically in an animal model of PD, many problems remain to be solved in order for ES cells to be used for clinical applications. This review will describe the current status of this field and the obstacles yet to be overcome, and will outline future research approaches from the clinical perspective.
Asunto(s)
Embrión de Mamíferos/citología , Enfermedad de Parkinson/cirugía , Trasplante de Células Madre/métodos , Células Madre/citología , Técnicas de Cultivo de Célula/ética , Técnicas de Cultivo de Célula/métodos , Humanos , Enfermedad de Parkinson/patología , Trasplante de Células Madre/éticaAsunto(s)
Técnicas de Cultivo de Célula/métodos , Biología Evolutiva/ética , Biología Evolutiva/métodos , Células Germinativas/citología , Células Germinativas/fisiología , Animales , Animales Recién Nacidos , Técnicas de Cultivo de Célula/ética , Aberraciones Cromosómicas , Medios de Cultivo/química , Biología Evolutiva/tendencias , Femenino , Feto/citología , Feto/embriología , Células de la Granulosa/citología , Células de la Granulosa/fisiología , Humanos , Masculino , Ratones , Oocitos/citología , Oocitos/fisiología , Ovario/citología , Ovario/embriología , Técnicas Reproductivas Asistidas/ética , Técnicas Reproductivas Asistidas/tendencias , Espermatozoides/citología , Espermatozoides/fisiologíaRESUMEN
Ex vivo gene therapy is emerging as a promising approach for the treatment of neurodegenerative diseases and central nervous system (CNS) trauma. We have shown previously that human adult astrocytes can be expanded in vitro and can express various therapeutic transgenes (Ridet et al. [1999] Hum. Gene Ther. 10:271-280; Serguera et al. [ 2001] Mol. Ther. 3:875-881). Here, we grafted normal and lentivirally-modified human adult astrocytes into the striatum and spinal cord of nude mice to test whether they are suitable candidates for ex vivo CNS gene therapy. Transplanted cells survived for at least 2 months (longest time analyzed) and sustained transgene expression. Importantly, the absence of proliferating cell nuclear antigen (PCNA) staining, a hallmark of cell division, ascertains the safety of these cells. Thus, adult human astrocytes are a promising tool for human CNS repair; they may make autologous ex vivo gene transfer feasible, thereby avoiding the problems of immunological rejection and the side effects of immunosuppressors.